Search

everythinglearnresearchcommunity

for

Search:↓

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Women with PCOS are more likely to experience sexual dysfunction, but lifestyle changes and weight loss can improve sexual function.

Flibanserin may help improve sexual symptoms in various conditions beyond its approved use.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Married Egyptian women with PCOS have lower sexual desire compared to those without PCOS.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

PCOS increases sexual pain distress in infertile women.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Genetic mutations can affect female sexual development, requiring personalized medical care.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

The therapies improved ejaculation disorders and sexual function in middle-aged men.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

The questionnaire is valid and reliable but needs more testing for future predictions.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Women with PCOS often have sexual problems, and treating these issues early can improve satisfaction and reduce healthcare costs.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.